Literature DB >> 19390831

Every single cell clones from cancer cell lines growing tumors in vivo may not invalidate the cancer stem cell concept.

Fengzhi Li1.   

Abstract

We present the result of our research on the tumorigenic ability of single cell clones isolated from an aggressive murine breast cancer cell line in a matched allografting mouse model. Tumor formation is basically dependent on the cell numbers injected per location. We argue that in vivo tumor formation from single cell clones, isolated in vivo from cancer cell lines, may not provide conclusive evidence to disprove the cancer stem cell (CSC) theory without additional data.

Entities:  

Mesh:

Year:  2009        PMID: 19390831      PMCID: PMC2821190          DOI: 10.1007/s10059-009-0056-5

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  5 in total

1.  Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice.

Authors:  Andrew Ewens; Liqun Luo; Erica Berleth; James Alderfer; Robert Wollman; Bilal Bin Hafeez; Peter Kanter; Enrico Mihich; M Jane Ehrke
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

Review 2.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions.

Authors:  Jane E Visvader; Geoffrey J Lindeman
Journal:  Nat Rev Cancer       Date:  2008-09-11       Impact factor: 60.716

3.  Most C6 cells are cancer stem cells: evidence from clonal and population analyses.

Authors:  Xuesheng Zheng; Gang Shen; Xiaofeng Yang; Weiguo Liu
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

4.  The cancer stem cell theory: is it correct?

Authors:  Min-Hyuk Yoo; Dolph L Hatfield
Journal:  Mol Cells       Date:  2008-11-30       Impact factor: 5.034

5.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

  5 in total
  3 in total

Review 1.  Cervical cancer stem cells.

Authors:  Tingting Yao; Rongbiao Lu; Yizhen Zhang; Ya Zhang; Chenyang Zhao; Rongchun Lin; Zhongqiu Lin
Journal:  Cell Prolif       Date:  2015-12       Impact factor: 6.831

2.  Generation of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: survivin expression overlaps with stem cell markers.

Authors:  Fengzhi Li; Qiuying Cheng; Xiang Ling; Aimee Stablewski; Lei Tang; Barbara A Foster; Candace S Johnson; Youcef M Rustum; Carl W Porter
Journal:  Am J Pathol       Date:  2010-02-04       Impact factor: 4.307

3.  Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types.

Authors:  Xiang Ling; Diane Calinski; Asher A Chanan-Khan; Muxiang Zhou; Fengzhi Li
Journal:  J Exp Clin Cancer Res       Date:  2010-01-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.